Characteristics of COPD patients according to GOLD classification and clinical phenotypes in the Russian federation: The SUPPORT trial
Arkhipov V., Arkhipova D. E., Miravitlles M., Lazarev A., Stukalina E.
International Journal of Chronic Obstructive Pulmonary Disease
Vol.12, P. 3255-3262
Опубликовано: 2017
Тип ресурса: Статья
Аннотация:
Background: The high prevalence of COPD in the Russian Federation has been demonstrated in several epidemiological studies. However, there are still no data on the clinical characteristics of these patients according to Global Initiative for Chronic Obstructive Lung Disease (GOLD) groups and phenotypes, which could provide additional understanding of the burden of COPD, routine clinical practice, and ways to improve the treatment of patients with COPD in Russia. Patients and methods: SUPPORT was an observational multicenter study designed to obtain data about the distribution of patients with previously diagnosed COPD according to the severity of bronchial obstruction, symptom severity, risk of exacerbation, COPD phenotypes, and treatment of COPD. We included patients with a previous diagnosis of COPD who visited one of 33 primary-care centers for any reason in 23 cities in Russia. Results: Among the 1,505 patients with a previous diagnosis of COPD who attended the primary-care centers
Ключевые слова:
COPD; Observational study; Phenotypes; Russian Federation; Spirometry
beta 2 adrenergic receptor stimulating agent; bronchodilating agent; corticosteroid; long acting drug; muscarinic receptor blocking agent; short acting drug; bronchodilating agent; corticosteroid; adult; Article; asthma; bronchus obstruction; chronic bronchitis; chronic obstructive lung disease; clinical feature; cross-sectional study; disease classification; disease exacerbation; disease severity; female; health care facility; human; major clinical study; male; multicenter study (topic); observational study; patient assessment; phenotype; practice guideline; primary medical care; risk factor; Russian Federation; spirometry; symptom; aged; chronic obstructive lung disease; classification; clinical trial; comorbidity; diagnostic error; disease exacerbation; drug effect; lung; middle aged; multicenter study; nomenclature; pathophysiology; phenotype; predictive value; reproducibility; severity of illness index; spirometry; treatment outcome; Adrenal Cortex Hormones; Aged; Bronchodilator A
Язык текста: Английский
ISSN: 1178-2005
Arkhipov V.
Arkhipova D. E. Dariya Evgenyevna 1967-
Miravitlles M.
Lazarev A.
Stukalina E.
Архипов В.
Архипова Д. Е. Дария Евгеньевна 1967-
Миравитллес М.
Лазарев А.
Стюкалина Е.
Characteristics of COPD patients according to GOLD classification and clinical phenotypes in the Russian federation: The SUPPORT trial
Текст визуальный непосредственный
International Journal of Chronic Obstructive Pulmonary Disease
Vol.12 P. 3255-3262
2017
Статья
COPD Observational study Phenotypes Russian Federation Spirometry
beta 2 adrenergic receptor stimulating agent bronchodilating agent corticosteroid long acting drug muscarinic receptor blocking agent short acting drug bronchodilating agent corticosteroid adult Article asthma bronchus obstruction chronic bronchitis chronic obstructive lung disease clinical feature cross-sectional study disease classification disease exacerbation disease severity female health care facility human major clinical study male multicenter study (topic) observational study patient assessment phenotype practice guideline primary medical care risk factor Russian Federation spirometry symptom aged chronic obstructive lung disease classification clinical trial comorbidity diagnostic error disease exacerbation drug effect lung middle aged multicenter study nomenclature pathophysiology phenotype predictive value reproducibility severity of illness index spirometry treatment outcome Adrenal Cortex Hormones Aged Bronchodilator A
Background: The high prevalence of COPD in the Russian Federation has been demonstrated in several epidemiological studies. However, there are still no data on the clinical characteristics of these patients according to Global Initiative for Chronic Obstructive Lung Disease (GOLD) groups and phenotypes, which could provide additional understanding of the burden of COPD, routine clinical practice, and ways to improve the treatment of patients with COPD in Russia. Patients and methods: SUPPORT was an observational multicenter study designed to obtain data about the distribution of patients with previously diagnosed COPD according to the severity of bronchial obstruction, symptom severity, risk of exacerbation, COPD phenotypes, and treatment of COPD. We included patients with a previous diagnosis of COPD who visited one of 33 primary-care centers for any reason in 23 cities in Russia. Results: Among the 1,505 patients with a previous diagnosis of COPD who attended the primary-care centers